In agreement with a report on the predominant expression of ROS in CD45+CECs compared to their CD45− siblings in an animal tumor model (23), we observed that CD45+CECs consistently expressed higher levels of ROS in comparison to their CD45− counterparts. Here, PTPRC is linked to neoplasm.